Fig. 3.
Kaplan–Meier estimates of median overall survival according to the best overall response rate in patients with advanced melanoma treated with first-line BRAF-MEK inhibitors. Fourteen patients were not evaluable for response.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.